Aardvark Therapeutics (AARD) Earnings Date & Reports

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AARD is expected to report earnings to fall 19.19% to -80 cents per share on November 12

Aardvark Therapeutics AARD Stock Earnings Reports

Q3'26

Est.

$-0.80

Q1'26

Missed

by $0.22

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.04

The last earnings report on May 07 showed earnings per share of -99 cents, missing the estimate of -76 cents. With 141.96K shares outstanding, the current market capitalization sits at 110.74M.

View a ticker or compare two or three

AARD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AARD